share_log

REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday

REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday

REX American Resources公佈了樂觀的收益，週四加入了Avalo Therapeutics、RH和其他走高的大型股票
Benzinga ·  03/28 23:00

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday.

美國股市小幅上漲，標準普爾500指數週四上漲約0.1％。

Shares of REX American Resources Corporation (NYSE:REX) rose sharply during Thursday's session following upbeat quarterly earnings.

繼樂觀的季度收益之後，REX美國資源公司（紐約證券交易所代碼：REX）的股價在週四的交易日大幅上漲。

REX American Resources posted quarterly GAAP earnings of $1.16 per share, versus market estimates of 68 cents per share, according to data from Benzinga Pro.

根據Benzinga Pro的數據，REX American Resources公佈的季度GAAP收益爲每股1.16美元，而市場預期爲每股68美分。

REX American Resources shares jumped 23.2% to $54.15 on Thursday.

週四，REX美國資源股價上漲23.2％，至54.15美元。

Here are some other big stocks recording gains in today's session.

以下是今天交易日其他一些上漲的大型股票。

  • Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares gained 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million.
  • Hut 8 Corp. (NASDAQ:HUT) surged 20.4% to $11.87. Hut 8 Corp reported revenue of C$60.6 million for the six months ended Dec. 31, 2023.
  • RH (NYSE:RH) gained 16.2% to $344.99 following the release of quarterly results. RH posted weaker-than-expected results for its fourth quarter, but issued upbeat forecast.
  • Sutro Biopharma, Inc. (NASDAQ:STRO) climbed 14.4% to $5.64. Oppenheimer analyst Jay Olson maintained Sutro Biopharma with an Outperform and maintained a $10 price target.
  • Nikola Corporation (NASDAQ:NKLA) rose 12.7% to $1.0250.
  • OPKO Health, Inc. (NASDAQ:OPK) rose 12.1% to $1.1996. Labcorp announced acquisition of select assets of BioReference Health's Diagnostics Business.
  • Altimmune, Inc. (NASDAQ:ALT) gained 11.4% to $9.90. Altimmune recently released lean mass preservation data for pemvidutide and worse-than-expected fourth-quarter FY23 earnings.
  • Marathon Digital Holdings, Inc. (NASDAQ:MARA) climbed 10.4% to $24.37.
  • Guardant Health, Inc. (NASDAQ:GH) gained 8.4% to $19.48.
  • Opendoor Technologies Inc. (NASDAQ:OPEN) surged 8% to $3.1850.
  • Arhaus, Inc. (NASDAQ:ARHS) gained 7.7% to $15.94.
  • Riot Platforms, Inc. (NASDAQ:RIOT) rose 6.8% to $13.07.
  • BRP Inc. (NASDAQ:DOOO) gained 6.4% to $67.74 after the company reported fourth-quarter results.
  • Encompass Health Corporation (NYSE:EHC) gained 5.8% to $82.06. Barclays analyst Andrew Mok maintained Encompass Health with an Overweight and raised the price target from $95 to $101.
  • The Estée Lauder Companies Inc. (NYSE:EL) rose 5.4% to $152.85 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $160 to $170.
  • Exact Sciences Corporation (NASDAQ:EXAS) gained 4.7% to $70.01.
  • Avalo Therapeutics, Inc.（納斯達克股票代碼：AVTX）股價上漲430％，至25.35美元，此前該公司宣佈通過收購私人控股的AlmataBio收購了可用於第二階段的抗IL-1β單抗體（稱爲 AVTX-009）。該公司還宣佈了高達1.85億美元的私募融資。
  • 哈特8公司（納斯達克股票代碼：HUT）上漲20.4％，至11.87美元。Hut 8 Corp報告稱，截至2023年12月31日的六個月中，收入爲6,060萬加元。
  • 公佈季度業績後，RH（紐約證券交易所代碼：RH）上漲16.2％，至344.99美元。RH公佈的第四季度業績低於預期，但發佈了樂觀的預測。
  • Sutro Biopharma, Inc.（納斯達克股票代碼：STRO）上漲14.4％，至5.64美元。奧本海默分析師傑伊·奧爾森維持了Sutro Biopharma的跑贏大盤，並維持了10美元的目標股價。
  • 尼古拉公司（納斯達克股票代碼：NKLA）上漲12.7％，至1.0250美元。
  • OPKO Health, Inc.（納斯達克股票代碼：OPK）上漲12.1％，至1.1996美元。Labcorp宣佈收購BioReference Health診斷業務的部分資產。
  • Altimmune, Inc.（納斯達克股票代碼：ALT）上漲11.4％，至9.90美元。Altimmune最近發佈了pemvidutide的精益大規模保護數據，而23財年第四季度的收益則低於預期。
  • 馬拉松數字控股公司（納斯達克股票代碼：MARA）上漲10.4％，至24.37美元。
  • Guardant Health, Inc.（納斯達克股票代碼：GH）上漲8.4％，至19.48美元。
  • 開門科技公司（納斯達克股票代碼：OPEN）上漲8％，至3.1850美元。
  • 阿豪斯公司（納斯達克股票代碼：ARHS）上漲7.7％，至15.94美元。
  • 防暴平台公司（納斯達克股票代碼：RIOT）上漲6.8％，至13.07美元。
  • BRP公司（納斯達克股票代碼：DOOO）公佈第四季度業績後，上漲6.4％，至67.74美元。
  • Encomass Health Corporation（紐約證券交易所代碼：EHC）上漲5.8％，至82.06巴克萊分析師安德魯·莫克維持Encompass Health的增持，並將目標股價從95美元上調至101美元。
  • 雅詩蘭黛公司（紐約證券交易所代碼：EL）上漲5.4％，至152.85美元，此前Bof A證券將該股從中性上調至買入並將目標股價從160美元上調至170美元。
  • 精科科學公司（納斯達克股票代碼：EXAS）上漲4.7％，至70.01美元。

Now Read This: Bitcoin Trades Above $70,000 Following GDP, Jobless Claims Data; GateToken Emerges As Top Gainer

現在讀這個： 根據國內生產總值和申請失業救濟人數數據，比特幣交易價格超過70,000美元；GateToken成爲漲幅最大的股票

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論